Skip to main content

Table 1 Bovine sera selected for the present study from a serum panel previously used to validate the in-house Bb-cELISA1 [11]

From: Validation of a commercial version of a competitive enzyme linked immunosorbent assay for the detection of antibodies to Besnoitia besnoiti

Herd (number of herds)

Tests used to characterize sera

Status

Number (additional information)

Number of sera used for estimates of diagnostic sensitivity and specificity (reference)

Besnoitiosis herds (n = 2)

B. besnoiti tachyzoite IFAT, tachyzoite immunoblot, bradyzoite immunoblot, BbAPureELISA and Bb-cELISA1

Besnoitia positive

95 (positive IFAT titre, 1:100 [n = 19], 1:200 [n = 20], 1:400 [n = 18], 1:800 [n = 10], 1:1600 [n = 10], 1:3200 [n = 10], 1:6400 [n = 4])

95 (reference positive)

  

Besnoitia negative

9 (positive IFAT titre, 1:100 [n = 7], 1:200 [n = 1])

8 (reference inconclusive), 1 (reference negative)

Neosporosis herd (n = 1)

N. caninum p38 ELISA, N. caninum p38 avidity ELISA

Neospora positive

97 (including 6 with abortion)

97 (reference negative)

  

Neospora negative

4

4 (reference negative)

Sarcocystosis herd (n = 1)

Serologically not confirmed

Sera from suspected Sarcocystis spp. infectionsa

100

100 (reference negative)

  1. Besnoitia besnoiti antibodies in herds with besnoitiosis were assessed using B. besnoiti tachyzoite immunofluorescence antibody test (IFAT) and IFAT seropositivity (reciprocal titre ≥ 100) confirmed by B. besnoiti tachyzoite immunoblot, bradyzoite immunoblot and BbAPureELISA [11]. Seropositivity for N. caninum was determined by p38 ELISA and sera further characterized by p38 avidity ELISA (Additional file 1: Dataset S1)
  2. aAlthough the Sarcocystis spp. status of individual animals was unknown, frequent cases of eosinophilic myositis were recorded for this herd at slaughter